AF488 Anti-Human CD44 Antibody[P2A1]

Introducing the AF488 Anti-Human CD44 Antibody [P2A1], a highly advanced and meticulously developed product designed to cater to the specific needs of scientific research and diagnostic applications. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD44 antigen in human samples.

The AF488 Anti-Human CD44 Antibody [P2A1] has been meticulously engineered using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reliability. Its superior binding affinity to the CD44 antigen enables accurate and precise identification and quantification of CD44 expression in various experimental settings.

This antibody is conjugated with AF488, a highly fluorescent dye known for its exceptional brightness and photostability. The AF488 label enhances the visualization and detection of CD44, facilitating efficient and reliable analysis in fluorescence microscopy, flow cytometry, and other imaging techniques. Its exceptional signal-to-noise ratio ensures clear and distinct results, even in low-abundance CD44-expressing samples.

The AF488 Anti-Human CD44 Antibody [P2A1] exhibits outstanding specificity, exhibiting minimal cross-reactivity with other antigens, thereby minimizing false-positive results. Its high sensitivity allows for the detection of even low levels of CD44 expression, enabling accurate characterization and quantification of CD44-positive cells or tissues.

This product is supplied in a convenient and user-friendly format, ensuring ease of use and compatibility with various experimental protocols. It is provided in a ready-to-use formulation, eliminating the need for time-consuming and error-prone antibody labeling procedures.

In summary, the AF488 Anti-Human CD44 Antibody [P2A1] is a highly reliable and efficient tool for the detection and analysis of CD44 expression in human samples. Its exceptional specificity, sensitivity, and user-friendly format make it an indispensable asset for researchers and diagnosticians alike, enabling groundbreaking discoveries and advancements in the field of biomedical research.